DSxHE Tutorial - What Works for Whom: Assessing Heterogeneous Treatment Effects
Thu 10 Sept
|Zoom
Join us for an interactive tutorial on assessing heterogeneous treatment effects, led by Dr Carly Brantner (Duke University). With live-coding in R, we'll cover traditional stats methods through to more advanced techniques, comparing what each approach reveals about how treatment effects vary.


Time & Location
10 Sept 2026, 14:00 – 15:30 BST
Zoom
About the event
Averages can be misleading: a treatment can look effective overall while doing little, or even causing harm, for large parts of the population it's meant to help. In other cases, a treatment that appears ineffective on average may actually help some groups of people. Heterogeneous treatment effects capture that variation: how a treatment's benefit differs from person to person, rather than just its average across a trial population. Understanding who benefits (and who doesn't) is central to delivering more equitable care.
Join us for a 90-minute interactive tutorial with Dr Carly Brantner (Duke University), who'll walk us through detecting and estimating and interpreting that variation - live-coding in R on a simulated dataset, based on real data comparing treatments for depression, moving from traditional approaches (interaction terms, stratified analysis) through to more advanced techniques such as causal forests. We'll see firsthand what each method reveals, and what it trades off, when it comes to identifying who a treatment actually works for.
This session is a partnership between DSxHE's Statistical Methods and Data Diversity Themes, in collaboration with Cancer Research UK.
Who it's for: Applied clinical / biomedical researchers and health data scientists — no heavy stats background required! You'll need some basic knowledge of the R programming language, and we'll send you a very small amount of pre-reading beforehand.
About the Data Diversity Theme
Health datasets often don’t reflect the diversity of the populations they aim to serve. This lack of representativeness can limit the generalisability of research, reduce the effectiveness of new tools, and risk widening health inequalities.
A partnership between Data Science for Health Equity and Cancer Research UK, the Data Diversity Theme brings together researchers, clinicians, funders, and patient advocates to co-create practical ways of embedding diversity across the research lifecycle. It is co-led by Dr Toral Gathani (University of Oxford) and Dr Brieuc Lehmann (UCL).
Any questions?
Please direct any queries to info@datascienceforhealthequity.com.
Tickets
Event Ticket
£0.00
Total
£0.00